• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸环丙孕酮治疗化脓性汗腺炎女性患者的双盲对照交叉试验。

A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.

作者信息

Mortimer P S, Dawber R P, Gales M A, Moore R A

出版信息

Br J Dermatol. 1986 Sep;115(3):263-8. doi: 10.1111/j.1365-2133.1986.tb05740.x.

DOI:10.1111/j.1365-2133.1986.tb05740.x
PMID:2944534
Abstract

In order to examine whether anti-androgen therapy was effective in hidradenitis suppurativa (HS), ethinyloestradiol 50 micrograms/cyproterone acetate 50 mg in a reverse sequential regimen was compared with ethinyloestradiol 50 micrograms/norgestrel 500 micrograms (Eugynon 50) in 24 female patients. Both treatments produced substantial improvement in disease activity. Seven patients cleared and have remained free of disease for 18 months, five patients improved, four remained unchanged, while two deteriorated. Cyproterone acetate was not clinically significantly more effective than E50, and both gave a similar reduction in free androgen index. Anti-androgen therapy appears to be beneficial in the treatment of hidradenitis suppurativa.

摘要

为了研究抗雄激素疗法对化脓性汗腺炎(HS)是否有效,将24例女性患者中采用反向序贯疗法的50微克乙炔雌二醇/50毫克醋酸环丙孕酮与50微克乙炔雌二醇/500微克炔诺孕酮(复方炔诺酮片50)进行了比较。两种治疗方法均使疾病活动度有显著改善。7例患者病情清除且18个月来未再发病,5例患者病情改善,4例无变化,2例病情恶化。醋酸环丙孕酮在临床上并不比复方炔诺酮片50更有效,两者使游离雄激素指数下降程度相似。抗雄激素疗法似乎对化脓性汗腺炎的治疗有益。

相似文献

1
A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.醋酸环丙孕酮治疗化脓性汗腺炎女性患者的双盲对照交叉试验。
Br J Dermatol. 1986 Sep;115(3):263-8. doi: 10.1111/j.1365-2133.1986.tb05740.x.
2
Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy.采用抗雄激素(醋酸环丙孕酮)和雌激素联合疗法治疗女性化脓性汗腺炎
Br J Dermatol. 1986 Sep;115(3):269-74. doi: 10.1111/j.1365-2133.1986.tb05741.x.
3
Cyproterone acetate and two doses of oestrogen in female acne; a double-blind comparison.
Br J Dermatol. 1988 Jan;118(1):95-9. doi: 10.1111/j.1365-2133.1988.tb01756.x.
4
Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.痤疮:四环素、雌激素-醋酸环丙孕酮及联合治疗的双盲临床与实验室试验
Br Med J (Clin Res Ed). 1985 Nov 2;291(6504):1231-5. doi: 10.1136/bmj.291.6504.1231.
5
[Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].用35微克炔雌醇和2毫克醋酸环丙孕酮(达英35)抑制排卵
Geburtshilfe Frauenheilkd. 1986 Jul;46(7):435-8. doi: 10.1055/s-2008-1026659.
6
[Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].醋酸环丙孕酮与炔雌醇治疗多毛症。对血清和尿液中雄激素及尿皮质醇的影响
Ugeskr Laeger. 1985 Aug 12;147(33):2589-93.
7
Hidradenitis suppurativa: an androgen-dependent disorder.化脓性汗腺炎:一种雄激素依赖性疾病。
Br J Dermatol. 1986 Sep;115(3):259-62. doi: 10.1111/j.1365-2133.1986.tb05739.x.
8
Anti-androgen treatment in women with acne: a controlled trial.
Br J Dermatol. 1986 Jun;114(6):705-16. doi: 10.1111/j.1365-2133.1986.tb04880.x.
9
[Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
Ugeskr Laeger. 1985 Aug 12;147(33):2594-6.
10
[Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
Fortschr Med. 1986 Jul 24;104(27-28):547-50.

引用本文的文献

1
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.欧洲化脓性汗腺炎/反向性痤疮S2k指南第2部分:治疗
J Eur Acad Dermatol Venereol. 2025 May;39(5):899-941. doi: 10.1111/jdv.20472. Epub 2024 Dec 19.
2
Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea.二甲双胍:痤疮、化脓性汗腺炎和酒渣鼻的潜在治疗方法。
Acta Derm Venereol. 2023 Dec 11;103:adv18392. doi: 10.2340/actadv.v103.18392.
3
Axillary Hidradenitis Suppurativa: A Comparison between Two Perforator Flap Reconstructive Approaches after Radical Surgical Management.
腋窝化脓性汗腺炎:根治性手术治疗后两种穿支皮瓣重建方法的比较
Plast Reconstr Surg Glob Open. 2023 Oct 6;11(10):e5301. doi: 10.1097/GOX.0000000000005301. eCollection 2023 Oct.
4
Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review.化脓性汗腺炎疾病严重程度及生活质量结局指标的趋势:范围综述
JMIR Dermatol. 2021 Oct 1;4(2):e27869. doi: 10.2196/27869.
5
The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review.《激素在化脓性汗腺炎中的作用:系统评价》。
Int J Mol Sci. 2022 Dec 3;23(23):15250. doi: 10.3390/ijms232315250.
6
Current Medical and Surgical Treatment of Hidradenitis Suppurativa-A Comprehensive Review.化脓性汗腺炎的当前医学与外科治疗——综述
J Clin Med. 2022 Dec 6;11(23):7240. doi: 10.3390/jcm11237240.
7
Top 100 most-cited publications in hidradenitis suppurativa: An updated bibliometric analysis.化脓性汗腺炎领域被引用次数最多的100篇出版物:最新文献计量分析
Front Med (Lausanne). 2022 Sep 8;9:995873. doi: 10.3389/fmed.2022.995873. eCollection 2022.
8
Demographic Gaps and Requirements for Participation: A Systematic Review of Clinical Trial Designs in Hidradenitis Suppurativa.人口统计学差距和参与要求:化脓性汗腺炎临床试验设计的系统评价。
Dermatology. 2023;239(1):45-51. doi: 10.1159/000526069. Epub 2022 Sep 15.
9
Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis.化脓性汗腺炎及共病生物标志物、可成药基因、新药与药物再利用——一项分子荟萃分析
Pharmaceutics. 2021 Dec 26;14(1):44. doi: 10.3390/pharmaceutics14010044.
10
Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New?非生物疗法治疗化脓性汗腺炎的医学管理:有哪些新进展?
Am J Clin Dermatol. 2022 Mar;23(2):167-176. doi: 10.1007/s40257-021-00667-8. Epub 2022 Jan 6.